High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

RECRUITING

NCT07205523

Sponsor: Yigeng Cao,MD,PhD

Summary

The High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) study is the first prospective real-world cohort of hematologic diseases and transplantation in the Qinghai-Tibet Plateau. Patients undergoing hematopoietic stem cell transplantation (HSCT) at Qinghai University Affiliated Hospital, together with their donors, are systematically enrolled. The registry collects demographic, diagnostic, treatment, prognosis, and medical expense information, as well as biospecimens for future analyses. Historical data are incorporated, and prospective data collection is ongoing with long-term follow-up planned. The registry is designed as a sustainable research infrastructure to provide comprehensive data on disease incidence, treatment patterns, outcomes, and resource utilization in a high-altitude setting.

Official title: High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT): A Prospective Real-World Cohort Study in the Qinghai-Tibet Plateau

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2023-09-01

Completion Date

2100-12-31

Last Updated

2025-10-03

Healthy Volunteers

No

Conditions

Hematopoietic Stem Cell Transplantation (HSCT)Acute Myeloid Leukemia (AML)Leukemias, Acute Myeloid Myeloid Leukemias, Acute Hemophilia Myelodysplastic Syndrome MDS Lymphoma Leukemia Aplastic Anemia Bleeding Disorders Bone Marrow Transplantation Multiple Myeloma Myeloma, Multiple Immune Reconstitution

Locations (1)

Affiliated Hospital of Qinghai University

Xining, Qinghai, China

Clinical Research Directory